Autoimmunity in psoriatic arthritis: pathophysiological and clinical aspects

Area of Science:

• Immunology
• Genetics
• Rheumatology

Background:

• Psoriatic arthritis (PsA) is an underdiagnosed autoimmune condition affecting patient quality of life.
• Its pathogenesis remains largely unknown, but autoimmune characteristics are increasingly recognized.
• Genetic predisposition is linked to the MHC class I region and other immune-related genes.

Purpose of the Study:

• To explore the autoimmune underpinnings of psoriatic arthritis.
• To identify genetic and immunopathological factors contributing to PsA development.
• To correlate immunopathological findings with clinical observations and treatment responses.

Main Methods:

• Analysis of genetic variations, including HLA and non-HLA gene polymorphisms (e.g., IL12B, IL23R).
• Examination of cellular infiltrates in entheseal and synovial tissues.
• Identification of autoantibodies (e.g., anti-LL-37, anti-ADAMTSL5) and regulatory T cell function.

Main Results:

• Genetic risk for PsA is associated with MHC class I and various non-HLA genes.
• Immunopathological findings include oligoclonal CD8+ T cells, germinal centers, and loss of regulatory T cell function.
• Specific autoantibodies and clinical autoimmune multimorbidity support an autoimmune basis for PsA.

Conclusions:

• PsA exhibits significant autoimmune features, supported by genetic, cellular, and serological evidence.
• Understanding these autoimmune mechanisms is crucial for diagnosing and treating PsA.
• Treatment responses to specific immunomodulatory therapies align with an autoimmune etiology.